358 related articles for article (PubMed ID: 20832406)
1. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice.
Bruna J; Udina E; Alé A; Vilches JJ; Vynckier A; Monbaliu J; Silverman L; Navarro X
Exp Neurol; 2010 Jun; 223(2):599-608. PubMed ID: 20188093
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.
Cavaletti G; Gilardini A; Canta A; Rigamonti L; Rodriguez-Menendez V; Ceresa C; Marmiroli P; Bossi M; Oggioni N; D'Incalci M; De Coster R
Exp Neurol; 2007 Mar; 204(1):317-25. PubMed ID: 17214983
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
[TBL] [Abstract][Full Text] [Related]
5. Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.
Gilardini A; Avila RL; Oggioni N; Rodriguez-Menendez V; Bossi M; Canta A; Cavaletti G; Kirschner DA
Neurotoxicology; 2012 Jan; 33(1):1-7. PubMed ID: 22079976
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models.
Carozzi VA; Chiorazzi A; Canta A; Meregalli C; Oggioni N; Cavaletti G; Marmiroli P
Exp Neurol; 2015 Feb; 264():92-102. PubMed ID: 25450467
[TBL] [Abstract][Full Text] [Related]
7. Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.
Carozzi V; Chiorazzi A; Canta A; Oggioni N; Gilardini A; Rodriguez-Menendez V; Avezza F; Crippa L; Ceresa C; Nicolini G; Bossi M; Cavaletti G
Eur J Cancer; 2009 Mar; 45(4):656-65. PubMed ID: 19091544
[TBL] [Abstract][Full Text] [Related]
8. In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™).
Canta A; Chiorazzi A; Carozzi V; Meregalli C; Oggioni N; Sala B; Crippa L; Avezza F; Forestieri D; Rotella G; Zucchetti M; Cavaletti G
Cancer Chemother Pharmacol; 2011 Oct; 68(4):1001-8. PubMed ID: 21327681
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated administration of low doses of cisplatin on the rat nervous system.
Cavaletti G; Petruccioli MG; Tredici G; Marmiroli P; Barajon I; Fabbrica D; Di Francesco A
Int J Tissue React; 1991; 13(3):151-7. PubMed ID: 1960015
[TBL] [Abstract][Full Text] [Related]
10. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.
Cavaletti G; Tredici G; Braga M; Tazzari S
Exp Neurol; 1995 May; 133(1):64-72. PubMed ID: 7601264
[TBL] [Abstract][Full Text] [Related]
11. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.
Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G
Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective interactions in rats between paclitaxel and cisplatin.
McKeage MJ; Haddad GG; Ding L; Galettis P; Screnci D; Zhuang L; Baguley BC
Oncol Res; 1999; 11(6):287-93. PubMed ID: 10691031
[TBL] [Abstract][Full Text] [Related]
13. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel.
Jamieson SM; Liu JJ; Connor B; Dragunow M; McKeage MJ
Neurotoxicology; 2007 Nov; 28(6):1092-8. PubMed ID: 17686523
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
Callizot N; Andriambeloson E; Glass J; Revel M; Ferro P; Cirillo R; Vitte PA; Dreano M
Cancer Chemother Pharmacol; 2008 Nov; 62(6):995-1007. PubMed ID: 18270703
[TBL] [Abstract][Full Text] [Related]
17. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.
Cavaletti G; Cavalletti E; Montaguti P; Oggioni N; De Negri O; Tredici G
Neurotoxicology; 1997; 18(1):137-45. PubMed ID: 9215996
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy.
Barajon I; Bersani M; Quartu M; Del Fiacco M; Cavaletti G; Holst JJ; Tredici G
Exp Neurol; 1996 Mar; 138(1):93-104. PubMed ID: 8593900
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.
Pisano C; Pratesi G; Laccabue D; Zunino F; Lo Giudice P; Bellucci A; Pacifici L; Camerini B; Vesci L; Castorina M; Cicuzza S; Tredici G; Marmiroli P; Nicolini G; Galbiati S; Calvani M; Carminati P; Cavaletti G
Clin Cancer Res; 2003 Nov; 9(15):5756-67. PubMed ID: 14654561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
